Pharmaceutical Cold Chain Logistics Market set for steady growth to US$27.11 Billion by 2033, led by North America 43% global market share.

Pharmaceutical Cold Chain Logistics Market Size reached US$18.61 Billion in 2024 and is expected to reach US$27.11 Billion by 2033, growing at a CAGR of 4.3% during the forecast period 2025-2033, according to DataM Intelligence report.

Market growth is driven by the rising demand for temperature-sensitive biopharmaceuticals, vaccines and biologics, increasing emphasis on quality assurance and regulatory compliance, and the growing need to maintain product safety and efficacy during storage and transportation. Additionally, expansion of global vaccine distribution networks, technological advancements in temperature monitoring, packaging and real-time tracking systems, and the increasing penetration of specialized cold storage infrastructure are further supporting market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/pharmaceutical-cold-chain-logistics-market?pratik

United States: Key Industry Developments
✅ December 2025: Cold Chain Technologies launched the CCT Tower Elite, a reusable temperature-controlled pallet shipper for pharmaceutical logistics, enhancing durability, consistent temperature maintenance, and efficiency in high-volume transport while reducing waste.
​
✅ April 2025: Cold Chain Technologies introduced the CCT Elite reusable pallet shipper, developed post-acquisition of Tower Cold Chain, designed for life sciences with improved temperature integrity for biologics and reduced spoilage risks in long-distance shipping.
​
✅ March 2025: DHL Supply Chain acquired CRYOPDP to expand its Pharma Specialized Network, bolstering capabilities for clinical trials, cell and gene therapies, and biopharma cold chain logistics across the U.S.
​
Asia Pacific / Japan: Key Industry Developments
✅ October 2025: Fujitsu, Logistics Knight Japan, and Isuzu Motors launched a joint pilot project for a pharmaceutical logistics platform, focusing on temperature control visualization, joint transport, and palletized operations to improve efficiency and GDP compliance.
​
✅ November 2025: Japanese government advanced Q1 regulatory reforms to reduce drug approval delays for cold-sensitive therapies, alongside public-private initiatives accelerating domestic logistics readiness and cold chain capacity.
​
✅ September 2025: Cold-chain logistics providers integrated phase-change materials and vacuum-insulated panels into packaging solutions, extending shelf-life for pharmaceuticals during long-distance transport and enhancing supply chain reliability.

Key Merges and Acquisitions(2025):
UPS completed the acquisition of German cold-chain pharma specialists Frigo-Trans and BPL on January 7, 2025, solidifying its leadership in pharmaceutical cold chain logistics across Europe by integrating advanced cryopreservation capabilities from -196°C to ambient temperatures and a pan-European transportation network for time-critical healthcare shipments.
​
DHL Group acquired CRYOPDP from Cryoport on March 31, 2025, enhancing its specialized pharma logistics for clinical trials, biopharma, and cell & gene therapies, while forming a strategic partnership to bolster temperature-controlled networks and first/last-mile coverage in the life sciences sector.
​
UPS finalized the acquisition of Andlauer Healthcare Group (AHG) on November 3, 2025, for $1.6 billion, accelerating its global cold chain and pharma capabilities with AHG's coast-to-coast North American network, reduced transit times, and improved end-to-end visibility for high-value, temperature-sensitive treatments.

Market Segmentation Analysis:
By Product Type
Vaccines lead the pharmaceutical cold chain logistics market, driven by global immunization demands and temperature-sensitive distribution needs.
Biopharmaceuticals follow closely, fueled by biologics growth like monoclonal antibodies requiring ultra-low temperatures.
Clinical trial materials and drugs/medicines hold smaller portions, emphasizing specialized handling for trials and specialty therapies.

By Service Type
Transportation dominates due to the need for refrigerated freight across air, sea, and road for global pharma exports.
Warehousing and value-added services (VAS) claim a significant share, supported by advanced refrigerated facilities in key regions.
Packaging and other services contribute modestly, focusing on insulated solutions for last-mile integrity.
​
By Temperature Range
Cryogenic (below -150°C) holds about 31.45% share in 2024, critical for advanced therapies like gene treatments.​
Refrigerated (2°C-8°C) leads for vaccines and biologics, with frozen (below -20°C) next for deeper cold needs.​
Ambient (15°C-25°C) serves stable drugs but trails in volume amid rising ultra-cold demands.

Purchase this report before year-end and unlock an exclusive 30% discount:https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-cold-chain-logistics-market?pratik (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
Rising Biologics & Vaccines Demand
Growth in biologics, cell & gene therapies, mRNA vaccines, and temperature-sensitive drugs requires reliable cold storage and transport.

Increasing Chronic & Infectious Diseases
Higher prevalence of cancer, diabetes, cardiovascular and infectious diseases fuels demand for temperature-controlled pharmaceuticals.

Expansion of Global Pharmaceutical Trade
Growing cross-border drug shipments and outsourcing of manufacturing increase the need for robust cold chain infrastructure.

Stringent Regulatory Compliance
Guidelines from WHO, FDA, EMA and GDP standards push companies to invest in advanced cold chain monitoring, packaging, and handling systems.

Technological Advancements in Cold Chain Solutions
Adoption of IoT, RFID, real-time temperature monitoring, data logging, AI-based analytics and automation enhances reliability and boosts market growth.

Growth in Clinical Trials & Precision Medicine
Increasing R&D activities and temperature-sensitive clinical trial materials drive cold chain logistics demand.

Regional Insights:
North America commands the largest share of the Pharmaceutical Cold Chain Logistics Market, estimated at around 43% in recent assessments, driven by advanced healthcare infrastructure, high demand for biologics and vaccines, substantial R&D investments, and robust cold chain networks in the US and Canada.
​
Europe follows as the second-largest region, benefiting from stringent regulatory standards like GDP compliance, established pharmaceutical trade across countries like Germany, France, and the UK, and growing needs for temperature-sensitive drug distribution, though exact shares vary by report amid steady expansion.
​
Asia Pacific ranks third in market share, yet exhibits the fastest growth potential with high CAGRs in nations such as China, India, and Japan, fueled by rising healthcare investments, expanding pharma manufacturing, government initiatives, and increasing exports of temperature-controlled products.

Speak to Our Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/pharmaceutical-cold-chain-logistics-market?pratik

Key Players:
Cardinal Health, AmerisourceBergen Corporation, Envirotainer AB, FedEx, United Parcel Service of America, Inc., Thermo King, Sonoco ThermoSafe, B Medical Systems India Private Limited, DoKaSch TEMPERATURE SOLUTIONS GmbH, and Nordic Cold Chain Solutions.

Key Highlights (Top 5 Key Players) :
Cardinal Health provides specialized pharmaceutical cold chain logistics with strict compliance to cGMP, ISO standards, and temperature control from 2°C to -196°C using validated shippers for 48-100+ hours, emphasizing sustainable packaging and early manufacturer collaboration.
​
AmerisourceBergen Corporation (now Cencora) offers advanced cold chain solutions including 130,950 sq. ft. of refrigerated storage at 2-8°C and freezer space, supporting biopharmaceutical distribution, clinical trials, and compliant specialty logistics via World Courier acquisition.
​
FedEx delivers comprehensive pharma cold chain services with passive packaging for 24-96+ hours using gel packs and dry ice, Envirotainer containers (-20°C to +20°C), and Deep Frozen Solutions (-150°C to -195°C) featuring real-time Priority Alert tracking.
​
United Parcel Service (UPS) specializes in healthcare cold chain with temperature-controlled facilities near key hubs, offering end-to-end solutions for pharmaceuticals, biologics, and devices across 200+ countries, including day-specific scheduling and 24/7 monitoring.
​
Envirotainer AB leads in temperature-sensitive shipments with a full portfolio covering all pharma life cycles, sizes, and ranges from cryogenic to room temperature, featuring live monitoring, 24/7 Control Tower, and sustainable reusable containers using 95% renewable energy.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?pratik

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele

This release was published on openPR.